Adelaide-based biotechnology company, TGR BioSciences, has today announced its second European license agreement since being granted a US Patent for its innovative CaptSure™ technology immunoassay earlier this year.

The license agreement with Prime Diagnostics, a developer of high-quality diagnostics, technologies and services for the agricultural sector, part of Wageningen UR in the Netherlands, will provide Prime Diagnostics with non-exclusive access to TGR’s CaptSure™ technology for use in its immunoassay products for the agricultural sector.

Under the agreement, TGR will also provide antibody conjugation services, which will allow Prime Diagnostics to access TGR’s proprietary antibody tagging and immobilisation technology.

Anne Hinton, CEO of TGR BioSciences, said that the license agreement would bring the two companies closer together and enable further collaboration.

“The association of TGR with Prime Diagnostics brings together two companies with complementary expertise,” she said.

“We look forward to expanding our relationship with Prime Diagnostics further, through the combination of our resources.”

In comparison to conventional assays, which usually involve three separate incubations over 2-3 days or more, CaptSure™ technology only requires a single incubation period and can be performed within an hour, without compromising sensitivity or quality. The simple and robust format of CaptSure™ greatly reduces the costs of labour in medium- and high-throughput screening laboratories and delivers more flexibility for planning of QA/QC operations to the industry. Therefore CaptSure™ technology is the new gold standard for high-throughput immunoassay technology development around the world.

Mrs. Jose van Beckhoven, Product Manager, Prime Diagnostics said that CaptSure™ technology is a welcome addition to their product line, primarily due to its speed and accuracy.

“Our tests, using CaptSure™ immunoassays to find key plant virus targets, have shown the TGR system to be sensitive and fast.”

“Prime Diagnostics is very pleased to be an early adopter of this technology to bring next-generation products to the potato, horticultural and ornamental industry for virus and bacteria detection.”

Established in 2001, TGR BioSciences Pty Ltd (TGR) is a private company located in Adelaide, Australia. TGR provides innovative solutions for biological research applications, with expertise in cell biology, biochemistry and immunoassay design. TGRs high quality products have been used successfully in drug discovery programs around the world.